Oak Ridge Investments LLC Has $2.32 Million Stock Position in Iradimed Corporation (NASDAQ:IRMD)

Oak Ridge Investments LLC reduced its holdings in Iradimed Corporation (NASDAQ:IRMDFree Report) by 3.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,146 shares of the medical equipment provider’s stock after selling 1,353 shares during the period. Oak Ridge Investments LLC owned approximately 0.33% of Iradimed worth $2,318,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. raised its stake in Iradimed by 189.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 66,632 shares of the medical equipment provider’s stock valued at $3,351,000 after purchasing an additional 43,635 shares during the last quarter. Eagle Asset Management Inc. bought a new stake in shares of Iradimed in the third quarter valued at about $1,239,000. Albert D Mason Inc. acquired a new stake in Iradimed during the third quarter worth about $737,000. Barclays PLC increased its stake in Iradimed by 113.9% during the third quarter. Barclays PLC now owns 23,774 shares of the medical equipment provider’s stock valued at $1,196,000 after acquiring an additional 12,657 shares during the period. Finally, Algert Global LLC raised its holdings in Iradimed by 84.1% in the 2nd quarter. Algert Global LLC now owns 26,774 shares of the medical equipment provider’s stock valued at $1,176,000 after acquiring an additional 12,227 shares in the last quarter. 92.34% of the stock is currently owned by institutional investors and hedge funds.

Iradimed Trading Up 1.4 %

Shares of NASDAQ:IRMD opened at $59.17 on Friday. The firm has a market capitalization of $749.68 million, a PE ratio of 40.53 and a beta of 0.81. Iradimed Corporation has a 1-year low of $40.18 and a 1-year high of $59.31. The business’s 50 day moving average is $54.76 and its 200-day moving average is $50.17.

Iradimed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Friday, November 15th were issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 1.01%. The ex-dividend date was Friday, November 15th. Iradimed’s dividend payout ratio (DPR) is presently 41.10%.

Insider Activity

In other news, CFO John Glenn sold 2,500 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $54.18, for a total value of $135,450.00. Following the completion of the transaction, the chief financial officer now directly owns 4,383 shares of the company’s stock, valued at approximately $237,470.94. This represents a 36.32 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 37.10% of the company’s stock.

About Iradimed

(Free Report)

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Featured Stories

Want to see what other hedge funds are holding IRMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iradimed Corporation (NASDAQ:IRMDFree Report).

Institutional Ownership by Quarter for Iradimed (NASDAQ:IRMD)

Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.